Prof. Dr. med. Mario Schiffer

Lehrstuhl für Innere Medizin IV

Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure (2021) Pietschner R, Kolwelter J, Bosch A, Striepe K, Jung S, Kannenkeril D, Ott C, et al. Journal article Oral health of patients suffering from end-stage solid organ insufficiency prior to solid organ re-transplantation: a retrospective case series study (2021) Möst T, Lutz R, Jahn AE, Heller KM, Schiffer M, Adler W, Deschner J, et al. Journal article Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine (2021) Ott C, Jung S, Korn M, Kannenkeril D, Bosch A, Kolwelter J, Striepe K, et al. Journal article Author Correction: Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis (Scientific Reports, (2021), 11, 1, (4577), 10.1038/s41598-021-83883-w) (2021) Müller-Deile J, Sarau G, Kotb AM, Jaremenko C, Rolle-Kampczyk UE, Daniel C, Kalkhof S, et al. Journal article, Erratum Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis (2021) Müller-Deile J, Sarau G, Kotb AM, Jaremenko C, Rolle-Kampczyk UE, Daniel C, Kalkhof S, et al. Journal article Use and preferences regarding internet-based health care delivery in patients with chronic kidney disease (2021) Schiffer L, Gertges R, Nöhre M, Schieffer E, Tegtbur U, Pape L, de Zwaan M, Schiffer M Journal article Transplant Ureteral Stenosis after Renal Transplantation: Risk Factor Analysis (2021) Apel H, Rother U, Wach S, Schiffer M, Kunath F, Wullich B, Heller KM Journal article Biallelic ANKS6 mutations cause late-onset ciliopathy with chronic kidney disease through YAP dysregulation (2021) Schwarz H, Popp B, Airik R, Torabi Sarijalo N, Knaup K, Stoeckert J, Wiech T, et al. Journal article, Original article BKPYV-SPECIFIC T CELLS REDUCE VIRAL LOAD IN A PRIMARY TUBULAR CELL MODEL (2021) Wasielewski E, Lippler S, Knaup K, Gary R, Aigner M, Kremer AL, Pfister F, et al. Conference contribution Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure (2021) Kolwelter J, Bosch A, Jung S, Stabel L, Kannenkeril D, Ott C, Bramlage P, et al. Journal article